APA (7th ed.) Citation

Carpenter, P. A., Logan, B. R., Lee, S. J., Weisdorf, D. J., Johnston, L., Costa, L. J., . . . Arora, M. (2018). A phase II/III randomized, multicenter trial of prednisone/sirolimus versus prednisone/ sirolimus/calcineurin inhibitor for the treatment of chronic graft- versus -host disease: BMT CTN 0801. Haematologica (Roma), 103(11), 1915-1924. https://doi.org/10.3324/haematol.2018.195123

Chicago Style (17th ed.) Citation

Carpenter, Paul A., et al. "A Phase II/III Randomized, Multicenter Trial of Prednisone/sirolimus Versus Prednisone/ Sirolimus/calcineurin Inhibitor for the Treatment of Chronic Graft- Versus -host Disease: BMT CTN 0801." Haematologica (Roma) 103, no. 11 (2018): 1915-1924. https://doi.org/10.3324/haematol.2018.195123.

MLA (9th ed.) Citation

Carpenter, Paul A., et al. "A Phase II/III Randomized, Multicenter Trial of Prednisone/sirolimus Versus Prednisone/ Sirolimus/calcineurin Inhibitor for the Treatment of Chronic Graft- Versus -host Disease: BMT CTN 0801." Haematologica (Roma), vol. 103, no. 11, 2018, pp. 1915-1924, https://doi.org/10.3324/haematol.2018.195123.